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AbstrACt
Objectives Pregnancy-related lumbopelvic pain (LPP) is 
a frequent condition known to significantly affect women 
in their daily life. The aetiology of pregnancy-related 
LPP pain is still not clearly established but the mode of 
conception has been suggested to contribute to LPP. 
Anxiety related to fertility treatments may be one of the 
contributing factors. The primary objectives of this study 
were to determine the evolution of LPP prevalence and 
severity, and anxiety throughout pregnancy in women who 
conceived spontaneously (SP) or after fertility treatments 
(FT). A further aim was to examine the relationship 
between pregnancy-related LPP severity and anxiety. The 
secondary objective was to determine the evolution of 
physical activity and their correlation with the severity of 
pregnancy-related LPP.
Design Prospective cohort study.
setting Pregnant women were recruited through 
physicians’ referrals, posters and newspaper 
advertisements in the local and surrounding communities 
(hospital, maternity care clinic, prenatal centres, sports 
centres, local university) in the city of Trois-Rivières, 
Canada.
Participants 59 pregnant women (33 SP and 26 FT) were 
assessed during the first, second and third trimester of 
pregnancy.
Primary and secondary outcome measures Pregnancy-
related LPP prevalence and severity (primary), trait and 
state anxiety, and physical activity levels (secondary).
results There was no relationship between the 
mode of conception and the outcome measures. The 
prevalence and severity of LPP increased over the course 
of pregnancy (time effect, p<0.0001) whereas trait 
anxiety decreased from early to mid-pregnancy (time 
effect, p=0.03). Activity limitations increased throughout 
pregnancy (time effect, p<0.0001) and physical activity 
levels decreased (time effect, p<0.0001). The severity 
of LPP was positively correlated with activity limitations 
(r=0.51 to 0.55) but negatively with physical activity levels 
(r=−0.39 to −0.41).
Conclusions Maternal health-related factors, such as LPP, 
anxiety and physical activity, are not different in women 
who conceived spontaneously or after fertility treatments. 
The more LPP was severe, the more the women were 
physically limited and inactive.
IntrODuCtIOn
More than 50% of women experience 
pain in the lumbopelvic area during preg-
nancy.1 Low back pain (LBP) is defined as 
pain localised below the ribs, but above 
the gluteal folds, with or without radia-
tion down the legs,2 whereas pelvic girdle 
pain (PGP) is defined as pain 'experienced 
between the posterior iliac crest and the 
gluteal fold, particularly in the vicinity of 
the sacroiliac joints. The pain may radiate 
in the posterior thigh and can also occur 
in conjunction with/or separately in the 
symphysis’.1 The term lumbopelvic pain 
(LPP) is used when no distinction is made 
between PGP and LBP.3 Thus the wide 
range of cases in the reported prevalence 
of LPP in the literature (45%–73%)4 5 has 
been attributed to the different criteria 
used to classify types and severity of pain, 
and the different periods during preg-
nancy LPP was assessed. The onset of LPP 
varies considerably, between the end of the 
strengths and limitations of this study
 ► This is a prospective cohort study of pregnant wom-
en who were assessed at each trimester of preg-
nancy, allowing to determine the evolution of several 
maternal health-related factors that are known to 
change over the course of pregnancy
 ► Primary and secondary outcomes were collected 
using validated tools
 ► The low number of women who achieved a preg-
nancy following in vitro fertilisation prevented us 
to fully test our hypotheses; thus larger studies 
are needed to better understand whether in vitro 
fertilisation contributes to pregnancy-related LPP
 ► More than half of the participants had a universi-
ty degree, which is not representative of our local 
population. The results may therefore not be broadly 
generalisable
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first trimester to the first month post-delivery, with a 
peak of symptoms generally occurring between the 
24th and 36th weeks of pregnancy.6 Pregnancy-related 
LPP is a debilitating condition that is known to affect 
women’s quality of life,7 with repercussions such as 
disruption of sleep, increased psychological stress, 
social and sexual life and work capacity.4 7–10 Pregnant 
women experiencing LPP are also known to be less 
physically active during pregnancy.11 Prenatal phys-
ical activity is an important component of a healthy 
pregnancy12 and all women without contraindication 
to exercise are encouraged to be regularly active 
throughout pregnancy to benefit from it.13 14 On the 
other hand, pregnancy-related LPP can contribute 
to maternal physical inactivity and its associated 
maternal, fetal and neonatal complications.12
Several factors are believed to be involved in preg-
nancy-related LPP development, such as degenera-
tive metabolic, genetic, hormonal and biomechanical 
factors and non-optimal joint stability.1 6 Another 
factor of interest is the mode of conception, in other 
words, naturally or after fertility treatments. A study 
reported that pregnant women who underwent in vitro 
fertilisation (IVF) treatments had a two times higher 
prevalence rate of sacral pain in early and late preg-
nancy, as well as a higher frequency of positive results 
on pelvic pain provocation tests in late pregnancy.15 
The authors concluded that relaxin causes pelvic pain 
because relaxin is higher in IVF pregnancies.16 Psycho-
social factors may also be involved in the development 
of LPP. Higher anxiety levels experienced in women 
who conceived after IVF might contribute to the 
higher pregnancy-related LPP prevalence observed 
in these women. As reported by a systematic review, 
women who conceived following fertility treatments 
had greater pregnancy-specific anxiety than those 
who conceived naturally.17 Based on a multi-centre 
study including 1158 women, higher levels of anxiety 
was reported to be among the most notable factors 
associated with a higher likelihood of reporting LBP.18 
However, to the best of our knowledge, no study has 
examined pregnancy-related LPP among women who 
achieve pregnancy naturally or after fertility treat-
ment, and whether anxiety is a contributing factor to 
the development of LPP.
Table 1 Baseline characteristics of the 59 pregnant women included in study
Variables FT (n=26), mean±SD SP (n=33), mean±SD P values
Fertility treatments OS=7
IUI = 12
IVF = 7 
–
Age (years) 32.2±3.6 30.9±4.2 0.23
Parity 0.4±0.6 0.6±0.6 0.36
  0 (n) 57.7% (15) 45.5% (15) 0.35
  ≥1 (n) 42.3% (11) 54.6% (18)
Prepregnancy BMI (kg/cm2) 26.3±7.3 25.2±6.6 0.54
  Underweight <18.4 0% (0) 3.1% (1) 0.81
  Normal weight (18.5–24.9) 60.0 (15) 62.5% (20)
  Overweight (25.0–29.9) 20.0 (5) 18.8% (6)
  Obese ≥30.0 20.0%(5) 15.6% (5)
Education levels
  Non-university degree 42.3% (11) 33.3% (11) 0.48
  University degree 57.7% (15) 66.7% (22)
LPP history (yes)* 46.2% (12) 54.6% (18) 0.52
Prevalence of pregnancy-related LPP over the last 
week (yes)
34.6% (9) 48.5% (16) 0.33
Severity of pregnancy-related LPP over the last week 2.9±1.9 4.1±2.3 0.18
State anxiety 37.4±11.6 34.2±9.1 0.28
Trait anxiety 39.8±10.0 37.1±9.4 0.26
Daily steps 5328±1551 5569±1552 0.8
Daily MVPA (min) 16.3±10.0 17.4±13.2 0.97
Missing data: prepregnancy BMI: 1 FT, 1 SP; state and trait anxiety: 1 SP; accelerometer data: 4 SP; 6 FT
*LPP history includes history of pregnancy-related LPP and LPP not related to pregnancy.
BMI, body mass index; FT, fertility treatment; IUI, intrauterine insemination; IVF, in vitro fertilisation; LPP , lumbopelvic pain; MVPA, moderate-
to-vigorous physical activity; OS, ovarian stimulation; SP, spontaneous conception.
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The primary objectives of this prospective cohort 
study were to determine the evolution of LPP preva-
lence and severity, as well as anxiety, over the course 
of pregnancy in women who conceived naturally or 
after fertility treatments, and to examine the possible 
relationship between pregnancy-related LPP severity 
and anxiety levels. As pregnancy-related LPP has a 
significant impact on women’s daily life activities, the 
secondary objective of our study was to determine the 
evolution of physical activity behaviours throughout 
pregnancy and whether the severity of LPP was 
correlated to these factors. Our primary hypotheses 
are that LPP prevalence and severity, as well as anxiety 
levels will increase over the course of pregnancy but 
more strongly in women who conceived after fertility 
treatments, and that pregnancy-related LPP severity 
will be positively correlated with anxiety levels. As 
a result, our secondary hypotheses are that activity 
limitations will increase whereas physical activity 
behaviours will decrease over the course of pregnancy 
but more significantly in women who conceived after 
fertility treatments, and that the severity of preg-
nancy-related LPP will be positively correlated with 
activity limitations but negatively with physical activity 
behaviours.
MAterIAls AnD MethODs
study design and selection of participants
This is a prospective cohort study of pregnant women who 
were recruited between October 2015 and September 
2016. Women who achieved a spontaneous pregnancy 
(SP group) and women who achieved pregnancy 
following fertility treatments (FT group) were recruited 
through referrals by physicians and clinic coordinators, 
posters and newspaper advertisements in the local and 
surrounding communities (hospital, maternity care 
clinic, prenatal centres, sports centres, local university) 
in the city of Trois-Rivières, Canada. Women under 14 
weeks of gestation, with a singleton pregnancy and able 
Figure 1 Prevalence of pregnancy-related lumbopelvic pain (LPP) in women who conceived spontaneously (SP) or after fertility 
treatments (FT) over the course of pregnancy. TR1: first trimester of pregnancy; TR2: second trimester of pregnancy; TR3: third 
trimester of pregnancy.
Figure 2 Evolution of pregnancy-related lumbopelvic pain (LPP) severity in women who conceived spontaneously (SP) or after 
fertility treatments (FT) over the course of pregnancy. TR1: first trimester of pregnancy; TR2: second trimester of pregnancy; 
TR3: third trimester of pregnancy.
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to understand, speak and write French were considered 
eligible to participate in the study. The study was approved 
by the local Research Ethics Committees (CER-2015–003 
and CER-15-214-07.10) and all participants provided their 
written informed consent.
Outcome measures and measurement tools
Women were followed from the first trimester of preg-
nancy until delivery through three evaluations (first 
trimester [TR1]: 10–16 weeks, second trimester [TR2]: 
24–28 weeks and third trimester [TR3]: 32–36 weeks of 
gestation). In each trimester, a member of the research 
team asked the women if they have had pregnancy-re-
lated LPP over the last 7 days or if they were having LPP 
presently using the illustration provided in the French 
version of the Pelvic Girdle Questionnaire (PGQ).19 If a 
woman had or was having pregnancy-related LPP, she was 
asked to rate pain intensity using a visual analogue pain 
scale. This scale is a self-reported measurement tool used 
by health professionals allowing the patient to rate pain 
from 0 (no pain) to 10 (extreme pain).20
The levels of anxiety was assessed during TR1, TR2 and 
TR3 using the French-Canadian version21 of the State-
Trait Anxiety Inventory (STAI).22 The STAI is a self-re-
ported questionnaire assessing the presence and severity 
of current symptoms of anxiety (state anxiety scale) and a 
generalised propensity to be anxious (trait anxiety scale). 
Each scale comprises 20 items rated with a 4-level Likert 
scale. The range of score for each scale is 20–80, with the 
higher score indicating greater anxiety levels. The STAI 
has been widely used in research with pregnant women 
and it does reflect the anxiety-related experiences of 
pregnant women. Its use with pregnant women is there-
fore appropriate.23
Activity limitations and symptoms associated with preg-
nancy-related LPP were assessed in TR2 and TR3 using the 
completed the French-Canadian version of the PGQ was 
used.19 The PGQ is a condition-specific measure devel-
oped for pregnant and postpartum women. It consists of 
20 activity items and five symptom items on a four-point 
response scale and assesses activity limitations and symp-
toms associated with pain in the lumbopelvic region. The 
range of score is 0%–100%, with a higher score indicating 
greater activity limitations and symptoms. The PGQ is reli-
able and valid for both pregnant and postpartum women 
with pregnancy-related LPP.24
Finally, physical activity levels were objectively 
measured at each trimester of pregnancy using the Acti-
Graph GT3X (ActiGraph, Pensacola, Florida, USA), a 
Figure 3 Evolution of trait anxiety in women who conceived spontaneously (SP) or after fertility treatments (FT) over the course 
of pregnancy. TR1: first trimester of pregnancy; TR2: second trimester of pregnancy; TR3: third trimester of pregnancy.
Figure 4 Evolution of state anxiety in women who conceived spontaneously (SP) or after fertility treatments (FT) over the 
course of pregnancy. TR1: first trimester of pregnancy; TR2: second trimester of pregnancy; TR3: third trimester of pregnancy.
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triaxial accelerometer measuring data in a 60 s epoch. 
The women were instructed to wear the monitor 
over the hip on an elastic belt for 7 consecutive days 
from wake-up time to bedtime. They were allowed to 
remove the accelerometer when sleeping, showering or 
engaging in water activities. Furthermore, the women 
received a daily diary to document wear and non-wear 
time periods and water activities. According to the 
method used in the Canadian Health Measures Survey, 
valid data were defined as 4 days or more of monitoring 
for 10 hours or more of wear time per day.25 Pregnant 
women were encouraged to maintain their usual activ-
ities. Data were processed using the Actilife software 
V.6.13.2 (ActiGraph, Florida, USA). The accelerometer 
data obtained were averaged across valid wear days. To 
derive the activity frequency, intensity and duration of 
the measured activity in counts per minute per day, the 
Freedson equation was used: sedentary (<100 counts), 
light (100–1951 counts), moderate (1952–5724), 
vigorous (5725–9498), and very vigorous (>9498),26 as 
previously used in pregnant women.27 Non-wear time 
was defined as a period of zero counts for ≥60 consecu-
tive minutes, admitting a maximum of two consecutive 
minutes between 1 and 100 counts/min. When a third 
observation was between 1 and 100 counts or one obser-
vation was more than 100 counts, the non-wear period 
was ended. Bouts of moderate-to-vigorous physical 
activity (MVPA)was defined as a minimum of 10 consec-
utive minutes above 1952 counts and ended with more 
than two consecutive records below this threshold.
Patient and public involvement
Patients and public were not involved in the design and 
conduct of this study. The results will not be disseminated 
to study participants.
statistical analysis
Means and SD, as well as percentages, were computerised 
for variables of interest. Student’s t-test was used to compare 
socio-demographic and anthropometric characteristics 
between SP and FT women. For categorical variables, the 
χ 2 test was used. The MIXED procedure of SAS software 
was used to test the effect of time (trimesters), group (SP 
and FT women) and potential interaction effects on the 
outcome measures (ie, the severity of pregnancy-related 
LPP and anxiety levels (objective 1), and physical activity 
behaviours (objective 2)). The assumption of sphericity 
was tested using Mauchly's Test of Sphericity. Variables 
Figure 5 Evolution of activity limitations in women who conceived spontaneously (SP) or after fertility treatments (FT) over the 
course of pregnancy. TR1: first trimester of pregnancy; TR2: second trimester of pregnancy; TR3: third trimester of pregnancy.
Figure 6 Evolution of daily moderate-to-vigorous physical activity (MVPA) in women who conceived spontaneously (SP) 
or after fertility treatments (FT) over the course of pregnancy. TR1: first trimester of pregnancy; TR2: second trimester of 
pregnancy; TR3: third trimester of pregnancy.
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that did not meet the sphericity assumption were analysed 
following a Geisser Greenhouse correction. When a signif-
icant effect of time, group or interaction effect was found, 
post-hoc analyses were conducted using the Tukey test. 
To test whether the severity of pregnancy-related LPP was 
correlated to the levels of anxiety (objective 1), and physical 
activity behaviours (objective 2) at each trimester of preg-
nancy, Pearson’s correlation analyses were used. Statistical 
analyses were performed by using the SAS software V.9.4 
and the level of significance was set to p value ≤0.05.
results
Between October 2015 and September 2016, the study 
was presented by physicians to 117 eligible pregnant 
women, among which 62 women accepted to participate. 
Reasons for not agreeing to participate to the study were 
lack of interest or lack of time. Three women (one in SP 
group and two in FT group) were excluded due to loss to 
follow-up (n=1), miscarriage (n=1) or missing data (n=1), 
leaving 59 women (33 SP and 26 FT) for the statistical 
analyses.
The characteristics of pregnant women are presented 
in table 1. No significant difference in socio-demographic 
and pre-pregnancy anthropometric characteristics was 
found between the groups (p>0.05). Women were on 
average in their early thirties and approximately half of 
them were nulliparous. More than half were of normal 
weight pre-pregnancy (body mass index 18.5–24.9 kg/m2) 
and had a university degree. Women’s LPP history, related 
or not to a previous pregnancy, was also similar between 
the groups, with approximately 50% of the women 
reporting a history of LPP (table 1). Finally, the preva-
lence and severity of pregnancy-related LPP, anxiety and 
physical activity levels were not different between SP and 
FT pregnant women at study entry (table 1). Data showed 
that on average, women considered LPP as moderate 
Figure 7 Evolution of daily step counts in women who conceived spontaneously (SP) or after fertility treatments (FT) over the 
course of pregnancy. TR1: first trimester of pregnancy; TR2: second trimester of pregnancy; TR3: third trimester of pregnancy.
Figure 8 Correlation between the severity of pregnancy-related lumbopelvic pain (LPP) and activity limitations in the second 
trimester of pregnancy (TR2).
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(4/10) and were slightly anxious (35/80). Moreover, 
based on daily steps and physical activity recommenda-
tions,28 29 our population was considered inactive.
In our study, a total of 8 (13.5%), 8 (13.5%) and 9 (15%) 
women removed the accelerometer to do water activi-
ties (aqua gym, swimming or bathing) during TR1, TR2 
and TR3, respectively. The accelerometer was removed 
between one and five times during the evaluation period, 
and for 10 to 225 min. Furthermore, physical activity data 
was missing for 10 (17%), 7 (12%) and 8 (14%) women 
at TR1, TR2 and TR3, respectively, because those women 
did not wear the accelerometer for at least 10 hours per 
day for at least 4 days.
The prevalence of pregnancy-related LPP was similar 
in both groups during each trimester of pregnancy (TR1: 
χ2 = 2.19, p=0.33; TR2: χ2 = 2.13, p=0.33; TR3: χ2 = 0.01, 
p=0.92); the pooled prevalence increased from 42% 
during TR1% to 65% during TR2% to 68% during TR3 
(χ2 = 8.45; p=0.01) (figure 1). Among women presenting 
with pregnancy-related LPP at one time point during 
pregnancy (n=44, 26 SP and 18 FT), pain severity signifi-
cantly increased over the course of pregnancy in both 
groups (time effect: F=14.81, p<0.0001. figure 2), with 
pain severity being significantly higher during TR2 and 
TR3 compared with TR1. Trait anxiety decreased over 
the course of pregnancy in both groups (time effect: 
F=3.93, p<0.03. figure 3), with lower levels during TR2 
compared with TR1, whereas state anxiety did not signifi-
cantly change (figure 4). Finally, activity limitations 
associated with pregnancy-related LPP increased (time 
effect: F=18.82, p<0.0001. figure 5) whereas daily steps 
decreased over the course of pregnancy in both groups 
(time effect: F=16.03, p<0.0001. figure 6). The only time 
by group interaction effect was found for daily MVPA 
(time effect: F=13.11, p<0.0001; time*group interaction 
effect: F=3.38, p=0.04. figure 7), with daily MVPA being 
lower in TR3 compared with TR1 and TR2 only in SP 
women.
Figure 9 Correlation between the severity of pregnancy-related lumbopelvic pain (LPP) and daily moderate-to-vigorous 
physical activity (MVPA) in the second trimester of pregnancy (TR2). 
Figure 10 Correlation between the severity of pregnancy-related lumbopelvic pain (LPP) and daily step counts in the second 
trimester of pregnancy (TR2). 
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Since changes in the severity of pregnancy-related LPP, 
levels of anxiety and physical activity behaviours were 
similar between the groups, the results from SP and FT 
women were pooled in the correlation analyses. Among 
women who presented with pregnancy-related LPP, no 
correlation was found during TR1 between the severity 
of pregnancy-related LPP and anxiety or physical activity 
levels. During TR2, the severity of pregnancy-related LPP 
was positively correlated with activity limitations (r=0.51, 
p=0.001, figure 8) but negatively with daily steps (r=−0.39, 
p=0.03, figure 9). No correlation was found with daily 
MVPA (figure 10). During TR3, we found a positive 
correlation between the severity of pregnancy-related 
LPP and activity limitations (r=0.55, p=0.0002, figure 11) 
and a negative correlation with daily MVPA (r=−0.41, 
p=0.02, figure 12). No correlation was found with daily 
steps (figure 13).
DIsCussIOn
To the best of our knowledge, this is the first cohort 
study assessing the course of pregnancy-related LPP prev-
alence and severity in pregnant women who conceived 
naturally and after fertility treatments, and also looking 
into a possible association with anxiety levels and physical 
activity behaviours. Overall, our primary results showed 
no differences in LPP prevalence and severity, or anxiety 
levels between women who achieved a pregnancy natu-
rally or after fertility treatments. As expected, the prev-
alence and severity of LPP increased over the course 
of pregnancy and were of similar magnitude than that 
reported in previous studies.10 18 Anxiety levels decreased 
from early to mid-pregnancy and were not correlated to 
the severity of LPP.
Figure 11 Correlation between the severity of pregnancy-related lumbopelvic pain (LPP) and activity limitations in the third 
trimester of pregnancy (TR3).
Figure 12 Correlation between the severity of pregnancy-related lumbopelvic pain (LPP) and daily moderate-to-vigorous 
physical activity (MVPA) in the third trimester of pregnancy (TR3).








pen: first published as 10.1136/bmjopen-2018-022508 on 1 November 2018. Downloaded from 
9Lardon E, et al. BMJ Open 2018;8:e022508. doi:10.1136/bmjopen-2018-022508
Open access
Only one study examined the evolution of the prev-
alence and severity of pregnancy-related PGP (PPGP) 
according to the mode of conception.15 This study was 
conducted in 31 women who conceived after IVF and 200 
women who conceived spontaneously and assessed PGP at 
12, 24 and 34 weeks of pregnancy. The authors found an 
increase in PPGP prevalence and severity over the course 
of pregnancy in all women, as we and other authors did.30 
However, they reported a two times higher rate of PPGP 
in early and late pregnancy in women who achieved a 
pregnancy after IVF compared with those who achieved a 
pregnancy naturally but similar severity of PPGP.15 Impor-
tantly, many IVF women carried multiple pregnancies in 
that study. Given that relaxin levels are higher after IVF16 
and that the number of fetuses is higher after IVF, and 
given that the mechanical load is higher in twin pregnan-
cies, it is difficult to establish what causes higher rates of 
PPGP after IVF in this previous study.
Our hypothesis was that higher anxiety levels reported 
in women who conceived after fertility treatments17 would 
contribute to higher pregnancy-related LPP prevalence 
and severity in this population of pregnant women. 
However, we did not find any difference in anxiety levels 
between women who conceived after fertility treatments 
and those who conceived naturally. There are several 
reasons that may explain our result. First, the majority of 
women included in our sample conceived after ovarian 
stimulation (OS, n=7) or intrauterine insemination 
(IUI, n=12), whereas the majority of studies included in 
Gourounti’s review reporting higher anxiety in women 
who conceived following fertility treatments were 
conducted in the context of IVF.17 Because the medical 
surveillance is more frequent and the procedure more 
invasive in the context of IVF, it is likely that IVF gener-
ates more anxiety than OS and IUI. This might partially 
explain why we found no differences in anxiety levels in 
our sample.
When examining anxiety levels over the course of 
pregnancy, we found a U-shaped curve, with a significant 
decrease in anxiety from TR1 to TR2 and a non-signifi-
cant trend toward an increase from TR2 to TR3. These 
findings are similar to those of previous studies.31 32 In 
contrast, whereas some studies reported higher anxiety 
in pregnant women with LBP or PGP,18 33 we found no 
correlation between anxiety levels and LPP severity. Our 
findings suggest that in our sample, anxiety and LPP were 
two independent phenomena.
Likewise, our secondary results showed no relationship 
between the mode of conception and physical limitations 
and physical activity behaviours, except for MVPA during 
TR3. The decrease in MVPA observed only in women who 
conceived naturally needs further investigation. Similar 
to previous studies,34–37 we found that with advancing 
pregnancy, physical limitations increased36–38 and phys-
ical activity behaviours decreased.34 35 39 Our data further 
showed that the greater pregnancy-related LPP severity 
the greater physical limitation and lower physical activity 
levels in mid- and late pregnancy. These results are also 
in accordance with previous studies reporting decreased 
physical activity levels as physical limitations and LBP 
increase with advancing pregnancy.36 40
limitations
The strength of our study is its longitudinal design that 
allowed us to examine the evolution of several maternal 
health-related factors that are known to change over the 
course of pregnancy, in the context of spontaneous preg-
nancies and pregnancies achieved following FT. More-
over, our study adds knowledge about the relationship 
between pregnancy-related LPP severity and physical 
activity behaviours. However, the current study has limita-
tions that should be acknowledged. First, our sample was 
heterogeneous with regard to fertility treatments used to 
achieve a pregnancy, with the majority of women having 
Figure 13 Correlation between the severity of pregnancy-related lumbopelvic pain (LPP) and daily step counts in the third 
trimester of pregnancy (TR3).
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conceived after OS or IUI. This may explain the lower prev-
alence of PPGP and anxiety levels in women who conceived 
after fertility treatments. The low number of women who 
achieved a pregnancy following IVF prevented us to fully 
test our hypotheses and further larger studies are needed to 
better understand whether IVF contribute to pregnancy-re-
lated. Second, more than half of the women we recruited 
had a university degree, which is more than in our local 
population (22.5%).41 This suggests a possible recruitment 
bias and limits the generalisability of our results. Third, 
although accelerometers provide a valid and objective 
measure of physical activity levels, non-waterproof acceler-
ometers underestimate several types of physical activity, such 
as water activities. In our data set, several women removed 
the accelerometer to do water activities (aqua gym, swim-
ming or bathing) during TR1, TR2 and TR3, suggesting 
that we possibly underestimated the level of physical activity 
of these women. We also had missing physical activity data 
because some women did not wear the accelerometer for 
at least 10 hours per day for at least 4 days. Finally, physical 
activity levels were assessed only for a 7 day period during 
each trimester of pregnancy. Given that each trimester lasts 
for more than a week, the data obtained and the results 
reported in relation to physical activity levels do not truly 
reflect the evolution of physical activity levels over each 
trimester and over the entire course of pregnancy. Never-
theless, the majority of the women stated in the daily diary 
that their physical activity behaviour over the 7 day period 
of evaluation reflected their habitual behaviours.
COnClusIOn
In conclusion, our findings suggest that maternal health-re-
lated factors, such as LPP, anxiety and physical activity 
behaviours, are not different in women who conceived 
after fertility treatments and those who conceived spon-
taneously. The lack of correlation between the severity 
of pregnancy-related LPP and anxiety levels suggests that 
they are two independent phenomena. The increase in 
LPP severity and activity limitations, and decrease in phys-
ical activity behaviours with advancing gestation, and the 
fact that the more severe LPP the greater activity limita-
tions and physical inactivity in mid- and late pregnancy 
underline the importance of pregnancy-related LPP 
management to allow pregnant women performing their 
daily activities.
Acknowledgements The authors would like to acknowledge and thank Sophie 
Drouin, the coordinator of the fertility clinic, as well as the medical team who 
assisted with the recruitment, and all the women who participated to the project.
Contributors S-MR, MD and VB contributed to the study concept and design; EL 
and AS-L acquired the data; S-MR, MD and EL performed the statistical analysis 
and interpreted the data; EL and SMR drafted the manuscript; MD, AS-L and VB 
critically reviewed the manuscript for important intellectual content. All authors read 
and approved the final manuscript.
Funding This study was funded by a start-up grant from the Univeristé du Québec 
à Trois-Rivières (Institutional funds for research). 
Competing interests None declared.
Patient consent Not required.
ethics approval The study was approved by the local Research Ethics Committees 
(CER-2015-003 and CER-15-214-07.10)
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement No additional data are available.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the use 
is non-commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
reFerenCes
 1. Vleeming A, Albert HB, Ostgaard HC, et al. European guidelines 
for the diagnosis and treatment of pelvic girdle pain. Eur Spine J 
2008;17:794–819.
 2. van Tulder M, Becker A, Bekkering T, et al. Chapter 3. European 
guidelines for the management of acute nonspecific low back pain in 
primary care. Eur Spine J 2006;15 Suppl 2:s169–s191.
 3. Wu WH, Meijer OG, Uegaki K, et al. Pregnancy-related pelvic girdle 
pain (PPP), I: Terminology, clinical presentation, and prevalence. Eur 
Spine J 2004;13:575–89.
 4. Gutke A, Ostgaard HC, Oberg B. Pelvic girdle pain and lumbar pain 
in pregnancy: a cohort study of the consequences in terms of health 
and functioning. Spine 2006;31:E149–55.
 5. Mogren IM, Pohjanen AI. Low back pain and pelvic pain during 
pregnancy: prevalence and risk factors. Spine 2005;30:983–91.
 6. Kanakaris NK, Roberts CS, Giannoudis PV. Pregnancy-related pelvic 
girdle pain: an update. BMC Med 2011;9:15.
 7. Olsson C, Nilsson-Wikmar L. Health-related quality of life and 
physical ability among pregnant women with and without back pain 
in late pregnancy. Acta Obstet Gynecol Scand 2004;83:351–7.
 8. Elden H, Lundgren I, Robertson E. Life's pregnant pause of pain: 
pregnant women's experiences of pelvic girdle pain related to daily 
life: a Swedish interview study. Sex Reprod Healthc 2013;4:29–34.
 9. Mogren I. Perceived health, sick leave, psychosocial situation, and 
sexual life in women with low-back pain and pelvic pain during 
pregnancy. Acta Obstet Gynecol Scand 2006;85:647–56.
 10. Wang SM, Dezinno P, Maranets I, et al. Low back pain during 
pregnancy: prevalence, risk factors, and outcomes. Obstet Gynecol 
2004;104:65–70.
 11. Owe KM, Nystad W, Bo K. Correlates of regular exercise during 
pregnancy: the norwegian mother and child cohort study. Scand J 
Med Sci Sports 2009;19:637–45.
 12. Mudd LM, Owe KM, Mottola MF, et al. Health benefits of physical 
activity during pregnancy: an international perspective. Med Sci 
Sports Exerc 2013;45:268–77.
 13. Davies GA, Wolfe LA, Mottola MF, et al. Exercise in pregnancy and 
the postpartum period. J Obstet Gynaecol Can 2003;25:516–29.
 14. ACOG Committee Opinion. Physical activity and exercise 
during pregnancy and the postpartum period. Obstet Gynecol 
2015;126:e135–42.
 15. Kristiansson P, Nilsson-Wikmar L, von Schoultz B, et al. Back pain 
in in-vitro fertilized and spontaneous pregnancies. Hum Reprod 
1998;13:3233–8.
 16. Kristiansson P, Svärdsudd K, von Schoultz B, et al. 
Supraphysiological serum relaxin concentration during pregnancy 
achieved by in-vitro fertilization is strongly correlated to the 
number of growing follicles in the treatment cycle. Hum Reprod 
1996;11:2036–40.
 17. Gourounti K. Psychological stress and adjustment in pregnancy 
following assisted reproductive technology and spontaneous 
conception: A systematic review. Women Health 2016;56:1–21.
 18. Kovacs FM, Garcia E, Royuela A, et al. Prevalence and factors 
associated with low back pain and pelvic girdle pain during 
pregnancy: a multicenter study conducted in the Spanish National 
Health Service. Spine 2012;37:1516–33.
 19. Girard MP, Marchand AA, Stuge B, et al. Cross-cultural adaptation of 
the pelvic girdle questionnaire for the french-canadian population. 
 J Manipulative Physiol Ther 2016;39:494–9.
 20. Ostelo RW, Deyo RA, Stratford P, et al. Interpreting change 
scores for pain and functional status in low back pain: towards 
international consensus regarding minimal important change. 
Spine 2008;33:90–4.
 21. Gauthier J, Bouchard S. Adaptation canadienne-française de la 
forme révisée du state–trait anxiety inventory de spielberger. Can J 
Behav Sci 1990;25:559–78.








pen: first published as 10.1136/bmjopen-2018-022508 on 1 November 2018. Downloaded from 
11Lardon E, et al. BMJ Open 2018;8:e022508. doi:10.1136/bmjopen-2018-022508
Open access
 22. Spielberger CD. Manual for the State-Trait Anxiety Inventory (Form Y. 
Palo Alto: Consulting Psychologist Press, 1983.
 23. Gunning MD, Denison FC, Stockley CJ, et al. Assessing maternal 
anxiety in pregnancy with the State‐Trait Anxiety Inventory (STAI): 
issues of validity, location and participation. J Reprod Infant Psychol 
2010;28:266–73.
 24. Stuge B, Garratt A, Krogstad Jenssen H, et al. The pelvic girdle 
questionnaire: a condition-specific instrument for assessing activity 
limitations and symptoms in people with pelvic girdle pain. Phys Ther 
2011;91:1096–108.
 25. Colley RC, Garriguet D, Janssen I, et al. Activité physique des 
adultes au Canada: résultats d'accélérométrie de l'Enquête 
Cannadienne sur les mesures de la santé de 2007-2009. Statistique 
Canada Rapports sur la santé 2011.
 26. Freedson PS, Melanson E, Sirard J. Calibration of the Computer 
Science and Applications, Inc. accelerometer. Med Sci Sports Exerc 
1998;30:777–81.
 27. Harrison CL, Thompson RG, Teede HJ, et al. Measuring physical 
activity during pregnancy. Int J Behav Nutr Phys Act 2011;8:19.
 28. Tudor-Locke C, Bassett DR. How many steps/day are enough? 
Preliminary pedometer indices for public health. Sports Med 
2004;34:1–8.
 29. Evenson KR, Mottola MF, Owe KM, et al. Summary of international 
guidelines for physical activity after pregnancy. Obstet Gynecol Surv 
2014;69:407–14.
 30. Kristiansson P, Svärdsudd K, von Schoultz B. Back pain during 
pregnancy: a prospective study. Spine 1996;21:702–9.
 31. Lee AM, Lam SK, Sze Mun Lau SM, et al. Prevalence, course, and 
risk factors for antenatal anxiety and depression. Obstet Gynecol 
2007;110:1102–12.
 32. Teixeira C, Figueiredo B, Conde A, et al. Anxiety and depression 
during pregnancy in women and men. J Affect Disord 
2009;119:142–8.
 33. Elden H, Gutke A, Kjellby-Wendt G, et al. Predictors and 
consequences of long-term pregnancy-related pelvic girdle 
pain: a longitudinal follow-up study. BMC Musculoskelet Disord 
2016;17:276.
 34. Evenson KR, Wen F. Prevalence and correlates of objectively 
measured physical activity and sedentary behavior among US 
pregnant women. Prev Med 2011;53:39–43.
 35. Rousham EK, Clarke PE, Gross H. Significant changes in 
physical activity among pregnant women in the UK as assessed 
by accelerometry and self-reported activity. Eur J Clin Nutr 
2006;60:393–400.
 36. Cramp AG, Bray SR. A prospective examination of exercise and 
barrier self-efficacy to engage in leisure-time physical activity during 
pregnancy. Ann Behav Med 2009;37:325–34.
 37. Robinson HS, Veierød MB, Mengshoel AM, et al. Pelvic girdle pain-
-associations between risk factors in early pregnancy and disability 
or pain intensity in late pregnancy: a prospective cohort study. BMC 
Musculoskelet Disord 2010;11:91.
 38. Chang HY, Lai YH, Jensen MP, et al. Factors associated with low 
back pain changes during the third trimester of pregnancy. J Adv 
Nurs 2014;70:1054–64.
 39. Downs DS, LeMasurier GC, DiNallo JM. Baby steps: pedometer-
determined and self-reported leisure-time exercise behaviors of 
pregnant women. J Phys Act Health 2009;6:63–72.
 40. Poston L, Briley AL, Barr S, et al. Developing a complex intervention 
for diet and activity behaviour change in obese pregnant women 
(the UPBEAT trial); assessment of behavioural change and process 
evaluation in a pilot randomised controlled trial. BMC Pregnancy 
Childbirth 2013;13:148.
 41. Statistics Canada. Labour Force Survey, special compilation, 








pen: first published as 10.1136/bmjopen-2018-022508 on 1 November 2018. Downloaded from 
